계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Ajax Therapeutics
company
About
Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $40M
- Industries
- Biotechnology,Life Science,Medical
- Founded date
- Jan 1, 2019
- Operating Status
- Active
Ajax Therapeutics is an NYC-based biotechnology company applying computational chemistry and structure-based technologies to develop novel small molecules for hematologic malignancies
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$40M
Ajax Therapeutics has raised a total of
$40M
in funding over 2 rounds. Their latest funding was raised on
Jun 1, 2021 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 1, 2021 | Series Unknown | $40M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Ajax Therapeutics is funded by 2 investors.
Schrödinger
and Inning One Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Schrödinger
|
— | Series Unknown |
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
